Vera Therapeutics, Inc.
VERA
$34.55
-$0.74-2.08%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
6/21/2026
-
MarketBeat
9/8/2026
-
MarketBeat
9/4/2026
-
Globe Newswire
9/3/2026
-
TipRanks
9/1/2026
-
Globe Newswire
Analysts Offer Insights on Healthcare Companies: Vera Therapeutics (VERA) and Gilead Sciences (GILD)
8/31/2026
-
TipRanks
8/28/2026
-
The Cerbat Gem
8/27/2026
-
The Cerbat Gem
8/27/2026
-
MarketBeat
8/27/2026
-
Tickeron - Stocks
8/26/2026
-
MarketBeat
8/25/2026
-
Nasdaq News: Stocks
8/25/2026
-
The Cerbat Gem
8/25/2026
-
MarketBeat
8/24/2026
-
TipRanks
8/24/2026
-
MarketBeat
8/22/2026
-
TipRanks
8/22/2026
-
Tickeron - Stocks
8/21/2026
-
Tickeron - Stocks
8/21/2026
-
Tickeron - Stocks
8/19/2026
-
Tickeron - Stocks
8/19/2026
-
Tickeron - Stocks
8/19/2026
-
MarketBeat
8/18/2026
-
Simply Wall St
6/12/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Monday, August 10, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 770 0077
Address
2000 Sierra Point Parkway
Suite 1200
Brisbane, CA 94005
Suite 1200
Brisbane, CA 94005
Country
Year Founded
Business Description
Sector
Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with immunological diseases. The...
more